Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists
- 1 March 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (6) , 901-906
- https://doi.org/10.1016/s0960-894x(99)00101-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Immunological localization of m1–m5 muscarinic acetylcholine receptors in peripheral tissues and brainPublished by Elsevier ,2002
- Pharmacologic treatment of cognition in Alzheimer's dementiaNeurology, 1998
- Epidemiology of Dementia and Alzheimer's DiseaseAmerican Journal of Geriatric Psychiatry, 1998
- Alzheimer's Disease: Cholinergic Therapy and BeyondAmerican Journal of Geriatric Psychiatry, 1998
- Advances and Challenges in the Prevention and Treatment of Alzheimer's DiseasePharmaceutical Research, 1998
- Enhanced acetylcholine release in the hippocampus and cortex during acquisition of an operant behaviorBrain Research, 1996
- Lipophilic muscarinic M2 antagonists as potential drugs for cognitive disordersDrugs of the Future, 1995
- Alzheimer's therapy: an approach to novel muscarinic ligands based upon the naturally occurring alkaloid himbacine.Bioorganic & Medicinal Chemistry Letters, 1992
- Identification of a Family of Muscarinic Acetylcholine Receptor GenesScience, 1987
- The Chemical Constituents of Himantandra (Galbulimima) Species. IV. The Structures of Himbacine, Himbeline, Himandravine, and HimgravineAustralian Journal of Chemistry, 1961